AAAAAA

   
Results: 1-7 |
Results: 7
PROCOLLAGEN TYPES I AND III AMINOTERMINAL PROPEPTIDE LEVELS DURING ACUTE RESPIRATORY-DISTRESS SYNDROME AND IN RESPONSE TO METHYLPREDNISOLONE TREATMENT
Authors: MEDURI GU TOLLEY EA CHINN A STENTZ F POSTLETHWAITE A
Citation: Gu. Meduri et al., PROCOLLAGEN TYPES I AND III AMINOTERMINAL PROPEPTIDE LEVELS DURING ACUTE RESPIRATORY-DISTRESS SYNDROME AND IN RESPONSE TO METHYLPREDNISOLONE TREATMENT, American journal of respiratory and critical care medicine, 158(5), 1998, pp. 1432-1441
PGE(1) ANALOG (MISOPROSTOL) REVERSES NSAID MEDIATED ORAL TOLERANCE (OT) INHIBITION
Authors: POSTLETHWAITE A WHELLER P MYERS L KANG A
Citation: A. Postlethwaite et al., PGE(1) ANALOG (MISOPROSTOL) REVERSES NSAID MEDIATED ORAL TOLERANCE (OT) INHIBITION, Arthritis and rheumatism, 41(9), 1998, pp. 394-394
TYPE-I COLLAGEN (CI) EPITOPE RECOGNITION BY SSC PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC)
Authors: POSTLETHWAITE A MCKOWN K SEYER J KANG A
Citation: A. Postlethwaite et al., TYPE-I COLLAGEN (CI) EPITOPE RECOGNITION BY SSC PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC), Arthritis and rheumatism, 41(9), 1998, pp. 1478-1478
INFLAMMATORY CYTOKINES IN THE BAL OF PATIENTS WITH ARDS - PERSISTENT ELEVATION OVER TIME PREDICTS POOR OUTCOME
Authors: MEDURI GU KOHLER G HENDLEY S TOLLEY E STENTZ F POSTLETHWAITE A
Citation: Gu. Meduri et al., INFLAMMATORY CYTOKINES IN THE BAL OF PATIENTS WITH ARDS - PERSISTENT ELEVATION OVER TIME PREDICTS POOR OUTCOME, Chest, 108(5), 1995, pp. 1303-1314
PLASMA AND BAL CYTOKINE RESPONSE TO CORTICOSTEROID RESCUE TREATMENT IN LATE ARDS
Authors: MEDURI GU HEADLY S TOLLEY E SHELBY M STENTZ F POSTLETHWAITE A
Citation: Gu. Meduri et al., PLASMA AND BAL CYTOKINE RESPONSE TO CORTICOSTEROID RESCUE TREATMENT IN LATE ARDS, Chest, 108(5), 1995, pp. 1315-1325
DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE
Authors: MORELAND LW PRATT PW MAYES MD POSTLETHWAITE A WEISMAN MH SCHNITZER T LIGHTFOOT R CALABRESE L ZELINGER DJ WOODY JN KOOPMAN WJ
Citation: Lw. Moreland et al., DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL USING CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY, CM-T412, IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING CONCOMITANT METHOTREXATE, Arthritis and rheumatism, 38(11), 1995, pp. 1581-1588
MINIMAL EFFICACY OF A DEPLETING CHIMERIC ANTI-CD4 (CM-T412) IN TREATMENT OF PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA) RECEIVING CONCOMITANT METHOTREXATE (MTX)
Authors: MORELAND L PRATT P MAYES M POSTLETHWAITE A WEISMAN M SCHNITZER T LIGHTFOOL R CALABRESE L KOOPMAN W
Citation: L. Moreland et al., MINIMAL EFFICACY OF A DEPLETING CHIMERIC ANTI-CD4 (CM-T412) IN TREATMENT OF PATIENTS WITH REFRACTORY RHEUMATOID-ARTHRITIS (RA) RECEIVING CONCOMITANT METHOTREXATE (MTX), Arthritis and rheumatism, 36(9), 1993, pp. 190000039-190000039
Risultati: 1-7 |